Achilles Therapeutics (ACHL) Short Interest Ratio & Short Volume $1.15 +0.01 (+0.88%) As of 03:59 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Achilles Therapeutics Short Interest DataAchilles Therapeutics (ACHL) has a short interest of 122,300 shares, representing 0.32% of the float (the number of shares available for trading by the public). This marks a 35.44% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 136,498 shares to cover all short positions.Current Short Interest122,300 sharesPrevious Short Interest90,300 sharesChange Vs. Previous Month+35.44%Dollar Volume Sold Short$139,422.00Short Interest Ratio0.7 Days to CoverLast Record DateDecember 31, 2024Outstanding Shares41,100,000 sharesFloat Size37,950,000 sharesShort Percent of Float0.32%Today's Trading Volume74,987 sharesAverage Trading Volume136,498 sharesToday's Volume Vs. Average55% Short Selling Achilles Therapeutics? Sign up to receive the latest short interest report for Achilles Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartACHL Short Interest Over TimeACHL Days to Cover Over TimeACHL Percentage of Float Shorted Over Time Achilles Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/2024122,300 shares $139,422.00 +35.4%0.3%0.7 $1.14 12/15/202490,300 shares $89,387.97 -33.9%0.2%0.6 $0.99 11/30/2024136,700 shares $146,952.50 -36.6%0.4%0.2 $1.08 11/15/2024215,700 shares $226,485.00 +35.4%0.6%0.3 $1.05 10/31/2024159,300 shares $160,096.50 -25.1%0.4%0.2 $1.01 10/15/2024212,600 shares $208,220.44 -40.6%0.6%0.3 $0.98 9/30/2024358,100 shares $365,262.00 +9,082.1%0.9%0.6 $1.02 9/15/20243,900 shares $2,818.92 No Change0.0%0 $0.72 8/31/20243,900 shares $2,808.00 -53.6%0.0%0.1 $0.72 8/15/20248,400 shares $6,216.00 -56.3%0.0%0.2 $0.74 Get the Latest News and Ratings for ACHL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Achilles Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/202419,200 shares $15,365.76 +92.0%0.1%0.3 $0.80 7/15/202410,000 shares $8,389.00 -9.9%0.0%0.1 $0.84 6/30/202411,100 shares $9,046.50 -52.8%0.0%0.1 $0.82 6/15/202423,500 shares $21,197.00 -15.5%0.1%0.1 $0.90 5/31/202427,800 shares $25,576.00 +101.5%0.1%0.1 $0.92 5/15/202413,800 shares $12,696.00 -42.5%0.0%0 $0.92 4/30/202424,000 shares $18,000.00 -36.5%0.1%0 $0.75 4/15/202437,800 shares $31,374.00 -49.5%0.1%0 $0.83 3/31/202474,800 shares $93,500.00 +8.6%0.2%0.1 $1.25 3/15/202468,900 shares $75,790.00 -55.2%0.2%0.1 $1.10 2/29/2024153,700 shares $202,884.00 +340.4%0.4%0.2 $1.32 2/15/202434,900 shares $33,497.02 +245.5%0.1%0.1 $0.96 1/31/202410,100 shares $9,393.00 -79.5%0.0%0 $0.93 1/15/202449,200 shares $43,591.20 +131.0%0.1%0.3 $0.89 12/31/202321,300 shares $18,935.70 -29.2%0.1%0.2 $0.89 12/15/202330,100 shares $26,187.00 +16.2%0.1%0.3 $0.87 11/30/202325,900 shares $21,395.99 -44.7%0.1%0.4 $0.83 11/15/202346,800 shares $37,486.80 +22.2%0.1%0.9 $0.80 10/31/202338,300 shares $32,938.00 +3.5%0.1%0.7 $0.86 10/15/202337,000 shares $33,448.00 -21.9%0.1%0.6 $0.90 9/30/202347,400 shares $43,129.26 +4.4%0.1%0.6 $0.91 9/15/202345,400 shares $40,360.60 +20.4%0.1%0.5 $0.89 8/31/202337,700 shares $34,325.85 -11.1%0.1%0.4 $0.91 8/15/202342,400 shares $41,128.00 -27.8%0.1%0.4 $0.97 7/31/202358,700 shares $59,874.00 +36.5%0.2%0.6 $1.02 7/15/202343,000 shares $42,570.00 +50.9%0.1%0.3 $0.99 6/30/202328,500 shares $26,938.20 -0.4%0.1%0.2 $0.95 6/15/202328,600 shares $28,030.86 +50.5%0.1%0.2 $0.98 5/31/202319,000 shares $19,000.00 +28.4%0.1%0.1 $1.00 5/15/202314,800 shares $14,356.00 +114.5%0.0%0.1 $0.97A simple pattern that works in any market (Ad)Right when most traders were getting bearish, The All-Weather Pattern signaled something different. Following this setup could've turned every $1,000 into $1,770 in just 48 hours. But here's what really gets me excited... You don't need to be glued to your screen all day, no complex formulas, no guessing. Just wait for a stock to close below The All-Weather Pattern, then check if it opens higher the next morning. That's it. While of course I cannot promise future returns or against losses… I've put together a complete breakdown of how this works, including the new stock that’s tending towards The All-Weather Pattern this week.If you’re interested, the complete details are all here. 4/30/20236,900 shares $5,727.00 -57.9%0.0%0 $0.83 4/15/202316,400 shares $14,596.00 +26.2%0.0%0.1 $0.89 3/31/202313,000 shares $12,447.50 +106.4%0.0%0.1 $0.96 3/15/20236,300 shares $5,827.50 -33.7%0.0%0 $0.93 2/28/20239,500 shares $10,450.00 -78.0%0.0%0 $1.10 2/15/202343,200 shares $48,384.00 +163.4%0.1%0.1 $1.12 1/31/202316,400 shares $20,336.00 -49.2%0.0%0 $1.24 1/15/202332,300 shares $38,114.00 -59.1%0.1%0.1 $1.18 12/30/202279,000 shares $71,100.00 -30.9%0.2%0.2 $0.90 12/15/2022114,300 shares $125,730.00 -9.3%0.3%0.7 $1.10 11/30/2022126,000 shares $254,520.00 +2.1%0.3%2.4 $2.02 11/15/2022123,400 shares $213,482.00 +72.4%0.3%2.5 $1.73 10/31/202271,600 shares $138,188.00 +37.4%0.2%2.7 $1.93 10/15/202252,100 shares $109,410.00 -1.1%0.1%1.9 $2.10 9/30/202252,700 shares $119,102.00 +6.3%0.1%1.6 $2.26 9/15/202249,600 shares $144,832.00 +4.2%0.1%1.4 $2.92 8/31/202247,600 shares $138,516.00 -5.0%0.1%1.2 $2.91 8/15/202250,100 shares $162,825.00 -5.8%0.1%1.2 $3.25 7/31/202253,200 shares $135,660.00 +0.6%0.1%1.1 $2.55 7/15/202252,900 shares $140,185.00 +0.8%0.1%0.9 $2.65 6/30/202252,500 shares $132,300.00 -18.7%0.1%0.5 $2.52 6/15/202264,600 shares $148,580.00 +7.1%0.2%0.6 $2.30 5/31/202260,300 shares $150,750.00 -30.0%0.2%0.5 $2.50 5/15/202286,100 shares $191,142.00 +41.9%0.2%0.8 $2.22 4/30/202260,700 shares $134,754.00 -59.8%0.2%0.6 $2.22 4/15/2022150,800 shares $357,396.00 +20.1%0.4%1.5 $2.37 3/31/2022125,600 shares $369,264.00 +114.0%0.3%1.6 $2.94 3/15/202258,700 shares $174,926.00 -2.3%0.2%1.1 $2.98 2/28/202260,100 shares $198,931.00 -19.5%0.2%0.9 $3.31 2/15/202274,700 shares $258,462.00 +3.8%0.2%1 $3.46 1/31/202272,000 shares $273,600.00 +6.2%0.2%0.6 $3.80 1/15/202267,800 shares $275,946.00 -12.4%0.2%0.5 $4.07 12/31/202177,400 shares $387,774.00 +4.5%0.2%0.4 $5.01 12/15/202174,100 shares $330,486.00 +9.9%0.2%0.3 $4.46 11/30/202167,400 shares $343,740.00 -95.3%0.2%0.3 $5.10 11/15/20211,430,000 shares $8.15 million +33.6%3.7%5.8 $5.70 10/29/20211,070,000 shares $6.57 million +21.3%2.7%3.7 $6.14 10/15/2021882,000 shares $6.71 million +15.2%2.3%3.4 $7.61 9/30/2021765,900 shares $5.97 million +29.0%2.0%3.4 $7.79 9/15/2021593,700 shares $3.45 million +1.3%1.5%4.5 $5.81 8/31/2021586,300 shares $3.98 million -0.9%1.5%4.7 $6.78 8/13/2021591,800 shares $3.82 million No Change1.5%5.2 $6.45 ACHL Short Interest - Frequently Asked Questions What is Achilles Therapeutics' current short interest? Short interest is the volume of Achilles Therapeutics shares that have been sold short but have not yet been covered or closed out. As of December 31st, traders have sold 122,300 shares of ACHL short. 0.32% of Achilles Therapeutics' shares are currently sold short. Learn More on Achilles Therapeutics' current short interest. What is a good short interest ratio for Achilles Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ACHL shares currently have a short interest ratio of 1.0. Learn More on Achilles Therapeutics's short interest ratio. What is a good short interest percentage for Achilles Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.32% of Achilles Therapeutics' floating shares are currently sold short. Is Achilles Therapeutics' short interest increasing or decreasing? Achilles Therapeutics saw a increase in short interest in the month of December. As of December 31st, there was short interest totaling 122,300 shares, an increase of 35.4% from the previous total of 90,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Achilles Therapeutics' float size? Achilles Therapeutics currently has issued a total of 41,100,000 shares. Some of Achilles Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Achilles Therapeutics currently has a public float of 37,950,000 shares. How does Achilles Therapeutics' short interest compare to its competitors? 0.32% of Achilles Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Achilles Therapeutics: ProQR Therapeutics (1.12%), Procaps Group S.A. (0.14%), Zentalis Pharmaceuticals, Inc. (6.37%), Cybin Inc. (3.51%), Compugen Ltd. (1.42%), Cardiff Oncology, Inc. (18.60%), Aclaris Therapeutics, Inc. (4.98%), Silence Therapeutics plc (3.29%), scPharmaceuticals Inc. (12.91%), Alector, Inc. (6.84%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short Achilles Therapeutics stock? Short selling ACHL is an investing strategy that aims to generate trading profit from Achilles Therapeutics as its price is falling. ACHL shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Achilles Therapeutics? A short squeeze for Achilles Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ACHL, which in turn drives the price of the stock up even further. How often is Achilles Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACHL, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies PRQR Short Squeeze PROC Short Squeeze ZNTL Short Squeeze CYBN Short Squeeze CGEN Short Squeeze CRDF Short Squeeze ACRS Short Squeeze SLN Short Squeeze SCPH Short Squeeze ALEC Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ACHL) was last updated on 1/21/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achilles Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Achilles Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
